Background: Reporting guidelines have been available for the past 17 years since the inception of the Consolidated Standards of Reporting Trials statement in 1996. These guidelines were developed to improve the quality of reporting of studies in medical literature. Despite the widespread availability of these guidelines, the quality of reporting of medical literature remained suboptimal. In this study, we assess the current adherence practice to reporting guidelines; determine key factors associated with better adherence to these guidelines; and provide recommendations to enhance adherence to reporting guidelines for future studies. Methods: We undertook a systematic scoping review of systematic reviews of adherence to reporting guidelines across different clinical areas and study designs. We searched four electronic databases (Cumulative Index to Nursing and Allied Health Literature, Web of Science, Embase, and Medline) from January 1996 to September 2012. Studies were included if they addressed adherence to one of the following guidelines: Consolidated Standards of Reporting Trials (CONSORT), Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA), Quality of Reporting of Meta-analysis (QUOROM), Transparent Reporting of Evaluations with Nonrandomized Designs (TREND), Meta-analysis Of Observational Studies in Epidemiology (MOOSE) and Strengthening the Reporting of Observational Studies in Epidemiology (STROBE). A protocol for this study was devised. A literature search, data extraction, and quality assessment were performed independently by two authors in duplicate. This study reporting follows the PRISMA guidelines. Results: Our search retrieved 5159 titles, of which 50 were eligible. Overall, 86.0% of studies reported suboptimal levels of adherence to reporting guidelines. Factors associated with better adherence included journal impact factor and endorsement of guidelines, publication date, funding source, multisite studies, pharmacological interventions and larger studies. Conclusion: Reporting guidelines in the clinical literature are important to improve the standards of reporting of clinical studies; however, adherence to these guidelines remains suboptimal. Action is therefore needed to enhance the adherence to these standards. Strategies to enhance adherence include journal editorial policies endorsing these guidelines.
Background
The medical literature is an integral component of clinical care, education, and research, as it has a serious impact on our understanding of health and disease. There are thousands of medical journals that publish articles related to clinical interventions, prognosis, diagnosis, and risks -among others -with an influence on health and life in general. For example, a quick glance at PubMed shows over 22 million citations for biomedical literature.
1 It is therefore a challenge to try to assimilate data presented in the literature and make evidence-based informed decisions. Attempts to summarize these data using systematic reviews are commendable as these reviews aim to provide a summary of the state of knowledge on a specific topic and address the inconsistent findings from single studies. However, these reviews are exponential in number and may report disparate findings. Searching for systematic reviews on depression resulted in 30,038 articles, 2 and in cancer resulted in 323,633. 3 One way to assimilate and disseminate knowledge that can influence decision-making and provide an understanding of a certain condition is to perform a systematic review of reviews. The past few decades have given rise to a handful of such studies in several clinical areas including lifestyle interventions, 4 interventions to improve mental health, 5 homeopathy, 6 medical education, 7 spinal manipulation, 8 sleep medicine, 9 and cancer, 10 among others. Each of these reviews of reviews is focused on a specific clinical question. There is a paucity of systematic reviews that assess the quality of reporting of clinical studies across different clinical areas, and that use different reporting guidelines. The EQUATOR (Enhancing Quality and Transparency in Health Research) network is an international initiative that supports the development and dissemination of such guidelines. 11 The EQUATOR website provides guidelines for the minimum information required to report research methods and findings for various kinds of medical research. 12 The evidence that is presented in the clinical literature can carry substantial weight in informing professionals and users of health care on multiple aspects of health risks, disease, health care outcomes, and delivery. However, readers of the literature are faced with conflicting results presented in various formats and styles, making interpretations and conclusions challenging even for the most informed readers. For this reason, a consensus on reporting such evidence is needed to establish the quality of such studies. It is also important to ensure that a more uniform method is used by researchers to enable the combination of results from multiple studies and reach more standardized summaries and conclusions; this can minimize heterogeneity, which often complicates meta-analyses in future studies. Furthermore, poorly reported research can cause harm to patients and lead to the use of scarce resources on ineffective treatments. 13 To address the concern over the quality of reported studies and ensure transparency in reporting clinical studies, the Consolidated Standards of Reporting Trials (CONSORT) 14 statement was produced as a collaborative effort to provide a checklist and flow diagram for authors to have as a guide to prepare reports on randomized controlled trials (RCTs) for publication. The CONSORT Statement was further updated in 2010 based on new evidence and an added focus on specific designs of RCTs. 15 The CONSORT is a widely accepted and adopted statement that is well described in many freely accessible publications and websites. In brief, the CON-SORT Statement provides a 25-item checklist describing the required criteria for inclusion when reporting RCTs. Such items include the study design, the participants, interventions, outcomes, and sample size among others. It also recommends the inclusion of a flow diagram, accounting for recruitment, randomization, allocation of interventions, and retention in the study. 16 Since the introduction of the CONSORT, several extensions and modifications of the original statement have been established to improve the quality of reporting of various study types, including observational studies, systematic reviews, and meta-analysis. Despite the availability of such guidelines for reporting, the quality of reporting of clinical studies has remained suboptimal with several manuscripts in a number of clinical areas missing key items as described in the CONSORT. [16] [17] [18] [19] [20] [21] [22] [23] Evidence suggests that the use of the CONSORT criteria is associated with improved standards of reporting. 24, 25 However, it is not clear what the current level of adherence to reporting guidelines is, what factors are associated with improving the reporting of clinical literature, and how the results from different studies on reporting standards can be compiled to provide an overall conclusion on the current state of reporting standards.
We therefore undertook a systematic scoping review evaluating systematic reviews addressing the adherence standards to reporting guidelines published since the introduction of the CONSORT Statement in January 1996 to September 2012.
Study aims
In this study, we aimed to examine the extent of adherence to reporting guidelines in published clinical research since the introduction of the CONSORT Statement in 1996. The purpose of this systematic scoping review is to inform researchers, guideline developers, journal editors, and evidence users on the profile of reporting the existing literature and the current state of knowledge in the application of these guidelines. In particular, we will endeavor to address the following questions:
(1) what is the current adherence to the reporting standards that include the CONSORT, 26 Strengthening the Reporting of Observational Studies in Epidemiology (STROBE), 27 Quality of Reporting of Meta-analysis -(QUOROM), 28 Transparent Reporting of Evaluations with Nonrandomized Designs (TREND), 29 Meta-analysis Of Observational Studies in Epidemiology submit your manuscript | www.dovepress.com
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(MOOSE), 30 and Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines? 31 (2) What are the factors that are associated with adherence to reporting standards in medical literature? And (3) what guidance can we provide based on the current state of knowledge on adherence to reporting standards? More specifically the objectives of this review are to: 1. Report the levels of adherence to the above reporting guidelines in clinical research; 2. Determine the key factors associated with adherence to good reporting; and 3. Provide recommendations to enhance adherence to reporting guidelines for future studies. We preselected the six guidelines above because they are among the oldest and the most popular, spanning through a wide range of study designs and clinical areas, and are therefore likely to be reported in systematic reviews, thus potentially generating a number of reviews to be included in this study.
Methods
We adopted a "systematic" scoping review approach -which is a combination of a scoping review methodology -to ensure the inclusion of broad areas of research and study designs, and a systematic review of reviews methodology. 32, 33 A scoping review is a relatively new type of study providing an assessment of available evidence from the literature in a broad area of research such as the compliance in the reporting of clinical studies to established guidelines. It also serves to identify gaps in the field and provide recommendations for implementation. 32 The methodology of scoping reviews was first described in detail by Arksey and O'Malley 32 in their pivotal paper published in 2005, which provided a foundation for carrying out a scoping review. This framework was further operationalized, and five stages were proposed to be followed when conducting a scoping review, including: (1) the identification of a research question; (2) finding the relevant studies; (3) the selection of studies to be included in the review; (4) data extraction from the included studies; and (5) assembling, summarizing, and reporting the results of the review. 34 The methods of conducting a systematic review of systematic reviews follow a similar approach, but include the provision of guidelines and suggestions for clinical practice, education, and research. 33 The aim of the methods and search strategy here is to ensure that the systematic review of reviews is comprehensive, thorough, and objective. We will report the results using the PRISMA (formerly QUOROM) reporting guidelines for systematic reviews. 35 A protocol was specifically designed for this study outlining the study design, search strategy, and selection criteria.
Data sources and search strategy
Electronic literature databases including Cumulative Index to Nursing and Allied Health Literature (CINAHL), Web of Science, Embase, and Medline (from January 1996 [date of CONSORT] to September 2012) were searched using a comprehensive search strategy designed with the assistance of a librarian who is experienced in conducting systematic reviews. The reference lists of identified articles were also reviewed for additional studies, and a manual search of key journals like BioMed Central systematic reviews, BioMed Central Research Methodology, and the Cochrane Library was conducted to avoid missing relevant reviews. Such search strategies are well supported for this type of systematic search and retrieval of relevant studies. 36, 37 The databases were searched for the following key search terms: (Systematic reviews OR reviews OR quality of reporting OR completeness of reporting) AND (CONSORT OR STROBE OR QUOROM OR QUORUM OR PRISMA OR TREND OR MOOSE) OR adherence. For Web of Science, we also performed a forward citation search of the publications pertaining to reporting guidelines, whose acronyms might have other meanings, such as TREND and QUORUM. This helped us to decrease the occurrence of false positives in our search.
Initially, no language limits were set to identify the number of non-English reviews; however, a limit was then set for English language reviews only (which was necessary due to the lack of resources required to translate reviews from other languages). We also set the limits to "human" and "published complete systematic reviews."
Inclusion criteria
1. Systematic reviews of clinical studies addressing the quality of reporting of the studies based on at least one of the six preselected reporting guidelines: CONSORT for RCTs; TREND for non-RCTs; STROBE for observational studies; and PRISMA (formerly QUOROM) or MOOSE for systematic reviews of RCTs or observational studies, respectively. 2. The systematic reviews must be complete (not abstracts only), reported in English, and investigating the quality of reporting in human studies of all age groups using one of the above guidelines.
3. The quality of reporting guidelines must be the primary focus of the systematic review.
Exclusion criteria
Systematic reviews were excluded if they were published as abstract only; the primary focus of the review was not on the quality of reporting; the quality of reporting was based on the standards of reporting that were different from the ones stated above, or if they were a duplicate publication of existing reviews (commentaries, letters, and editorials).
Selection of systematic reviews
Two independent reviewers examined the titles and abstracts of all citations identified in the literature search. Articles were selected for full-text review if the inclusion criteria were met and if both reviewers considered the citation potentially relevant. Disagreement at any stage of study selection was resolved by discussion and consensus between the two reviewers. If agreement could not be reached, a third author was recruited to determine eligibility. Initial agreement between the two reviewers was calculated using the kappa statistic. 38 Each reviewer independently: • Assessed retrieved titles and abstracts for relevance and duplication; • Screened full text articles deemed eligible for inclusion; • Decided on including or excluding articles; • Extracted relevant data using specifically designed data abstraction forms; • Appraised the quality of the included reviews.
A PRISMA flow diagram of included/excluded studies is provided (Figure 1 ). 35 Quality assessment of systematic reviews
The quality of each systematic review that met the inclusion criteria for the study was assessed using a modified version of the assessment of multiple systematic reviews (AMSTAR, a validated tool to assess the methodological quality of systematic reviews). [39] [40] [41] Certain items of AMSTAR are not relevant to this type of review and cannot be assessed (eg, item 9, "Were the methods used to combine the findings of studies appropriate?"), as pooling of data may not be feasible in all systematic reviews of methodological quality, and should relate to the study question. In addition, item 10 ("Was the likelihood of publication bias assessed?") is irrelevant to this review, which is focused on the quality of reporting of published studies. Both of these items were omitted from the quality assessment.
We also used the modified version of the enhanced Overview Quality Assessment Questionnaire (OQAQ) to assess the quality of systematic reviews included in this study. 42 In addition to these tools, we assessed the quality of the reviews based on the following criteria: the use of explicit criteria to assess individual study quality using the guidelines checklist; explicit definition of the research question using a flow diagram to explain study selection; and a formal sample size calculation for the assessment of association.
Data abstraction
A spreadsheet was created to record the following items from the selected reviews: authors, year of publication, number of primary studies included in the review, study location, study type, primary outcomes of the study, outcomes measures, and the overall results and conclusions. Two authors independently piloted the data extraction form for this review and modifications were made when necessary before reaching the final data abstraction forms used for this study. Data abstraction disagreements were resolved by discussion and consensus, and a third author extracted the data if an 
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Analysis
The level of agreement between raters was estimated using the kappa statistic. The adherence to reporting standards was summarized, and key determinants of adherence were identified in a narrative manner.
Results
Study selection
Our search retrieved 5159 articles from the four electronic databases searched. Following searching through the title, abstract, and full text screening, 50 articles were selected and included for data extraction and quality assessment ( Figure 1 ). The strength of agreement between two independent raters on abstract screening was substantial (Kappa = 0.65; 95% confidence interval [CI] 0.53, 0.76; P , 0.001), and almost perfect for full text screening (Kappa = 0.94; 95% CI 0.85, 1.00; P , 0.001). Agreement was also substantial for the quality assessment using the modified OQAQ/AMSTAR checklist (Kappa = 0.63; 95% CI 0.42, 0.85; P , 0.001).
Study characteristics
Forty-one studies (82.0%) assessed RCTs using the CON-SORT Statement, five (10.0%) studies used the QUOROM checklist, and two studies (4.0%) used the PRISMA tool. The final three systematic reviews (6.0%) consisted of two reviews assessing both RCTs and observational studies using the CONSORT and STROBE guidelines, and the last study used both the QUOROM and PRISMA guidelines. The systematic reviews were published in a wide variety of journals and were led by authors from many different countries (Table 1) . The median and interquartile range of the number of studies included in each review were 78 and 80.5, respectively.
Adherence to reporting guideline
The adherence of the studies included in the systematic reviews to their respective guidelines, and the author's conclusions, are shown in Table 2 . Forty-three (86.0%) of the included studies concluded that the adherence to reporting guidelines was inadequate, poor, medium, or suboptimal, or that some improvement was needed. No combined, quantitative result was generated from the 50 systematic reviews due to differences in the measurement tools used by the individual reviews.
CONSORT Statement
The adherence of RCTs to the CONSORT Statement was assessed with different versions of the CONSORT checklist. These checklists ranged from eight to 63 items, except for two studies that used the 212 subitem, Nelson-MobergNorton Expanded CONSORT instrument and the 201 subitem Nelson-Moberg Expanded CONSORT instrument. The revisions of the CONSORT Statements were usually based on the specific field of the RCT, and the applicability of the items on the CONSORT checklist to that field. For instance, Bian et al 43 used a revised 63-item CONSORT checklist designed for Chinese Herbal Medicine clinical trials. In addition to the CONSORT checklist, four studies (Augestad et al, 44 Balasubramanian et al, 45 Kiehna et al, 46 and Moher et al) 47 also used the five-point Jadad instrument to assess the quality of the individual RCTs. 39 Of the 41 systematic reviews assessing RCTs reporting adherence to the CONSORT Statement, 33 (80%) of them concluded that some improvement was needed, or that the reporting quality was inadequate, poor, medium, or suboptimal (Table 3) . Furthermore, the authors recommended the use of the CONSORT Statement as a guideline to improve the quality of reporting of RCTs. Eight studies did not report inadequate reporting quality of RCTs. Froud et al 48 concluded that cluster randomized trials in oral health had a reasonable quality. Fung et al 49 reported that the overall level of reporting was acceptable and the reporting quality has improved since the creation of CONSORT and STROBE statements. Ladd et al 25 also concluded that the overall reporting quality had improved since 1994 and the articles published in journals that endorse the CONSORT Statement had the highest levels of adherence to reporting guidelines. Moher et al 47 only compared the quality of pediatric complementary and alternative medicine RCTs and reported 40% of the CONSORT checklist items were included in these RCTs. Montgomery et al 50 evaluated the RCTs qualitatively and found that there was a varying level of reporting quality in factorial trials of complex interventions in community settings. Plint et al 51 compared RCTs from CONSORT-endorsing and nonendorsing journals, and their results suggested some improvement in the quality of reporting when the CONSORT checklist is used. Wangge et al 52 suggested that adherence to reporting guidelines for noninferiority trials have improved slightly since the CON-SORT Statement has been published. Lastly, Zintzaras et al (combined PRISMA and QUOROM guideline) An integrated score consisting of the number of items completed over the total numbers of items on both the PRISMA and QUOROM criteria, resulting in cored ranking from 0% to 100% (excluding the items focused on in the abstract) Mean = 63% (range 45%-81%) on a scale of 0%-100% Systematic reviews of empirical computerized provider order-entry research had moderate quality 88 Adherence to the 27-item PRISMA checklist
Willis
Of the 236 meta-analyses included following selection: 1% reported the study protocol; 25% reported the searches used; 32% reported the results of a risk of bias assessment; and 35% reported the abstract as a structured summary Compliance with the PRISMA statement was generally poor; none of the review completely adhered to all 27 checklist items for the published meta-analyses of diagnostic tests QUOROM Bereza 56 18-item QUOROM checklist, ten-item checklist OQAQ used for scientific quality 61% ± 19% (median 60%, range 39%-94%) for the QUOROM checklist. 58%
± 28%
for OQAQ "Reporting/scientific quality was considered less than fairto-good. Stakeholders should strive for higher scientific quality of meta-analyses" Hemels 68 
18-item QUOROM checklist
On average 50.2% of the CONSORT items were reported The overall quality of reporting in the meta-analysis of RCTs in major depressive disorder was marginally acceptable Junhua 70 18-item QUOROM checklist, ten-item checklist OQAQ used for scientific quality
No combined score; methodological and reporting flaws in more than half of the review articles. Flaws were mainly in the literature search, characteristics of included and excluded studies, quality assessment of primary trials, and data merging
Methodology and reporting quality are poor in both systematic reviews and meta-analysis of TCM published in journals in the People's Republic of China 18-item QUOROM checklist, ten-item checklist OQAQ used for scientific quality
All systematic reviews were found to have good overall quality. OQAQ mean score was 5.02 (95% CI 3.71-6.32) Reporting quality of Cochrane musculoskeletal systematic reviews was generally good, with room for improvement Vigna- Taglianti   85 QUOROM-based checklist (score out of 50) 29.9/50 "Oncologists should be aware that they could be relying on poor underlying documents. Writing groups should be aware of methodological problems, and should consult the existing manuals for the preparation of guidelines" Weir 87 (combined PRISMA and QUOROM guideline) An integrated score consisting of the number of items completed over the total numbers of items on both the PRISMA and QUOROM criteria, resulting in cored ranking from 0% to 100% (excluding the items focused on in the abstract) 63% (range 45%-81%) on a scale of 0%-100% Systematic reviews of empirical computerized provider order-entry research were of moderate quality STROBE Cook 61 Quality of reporting, methodological quality, and the association between methodological quality and effect size
(90)
Reporting the quality of experimental research on health profession education was found to be generally suboptimal 
PRISMA, QUOROM, and STROBE statements
Three studies examined adherence to the PRISMA guidelines, and all concluded that the adherence of the assessed systematic reviews was poor or moderate. Ma et al 74 and Willis et al 88 used the 27-item PRISMA checklist to assess the level of adherence. Ma et al 74 found that systematic reviews on traditional Chinese medicine published in Chinese journals had low adherence to the PRISMA checklist. Willis et al 88 also concluded that adherence to the PRISMA checklist was generally poor for published meta-analyses of diagnostic tests. Weir et al 87 used an integrated score consisting of both the PRISMA and QUOROM criteria and found that systematic reviews of empirical computerized provider order-entry research were only of moderate quality.
The assessment of studies' adherence to the QUOROM guideline was done with the 18-item QUOROM checklist coupled with a ten-item OQAQ checklist in three studies. Bereza et al 56 and Junhua et al 70 reported that there was a need to improve the quality of reporting of reviews, while Shea et al 82 concluded that the quality of Cochrane musculoskeletal systematic reviews was good. Hemels et al 68 used only the QUOROM checklist and they concluded that the quality of meta-analyses in studies on major depressive disorder was marginally acceptable. Vigna-Taglianti et al 85 used the QUOROM checklist with a specific weighting system for each of the headings and the average score was 29.9/50. No conclusions concerning adherence were made, although the authors did recommend the use of manuals to prepare guidelines for the management of breast and colon cancers. Lastly, as described in the previous paragraph, Weir et al 87 used an integrated score containing both PRISMA and QUOROM criteria. 
Factors associated with adherence to reporting guidelines
Although we included systematic reviews assessing the adherence of research articles to four different guidelines, only systematic reviews related to the CONSORT Statement reported on the factors that were associated with adherence to the guideline (Table 4 ). The exception was Hemel et al, 68 who concluded that the overall quality of reporting of meta-analyses using the QUOROM guidelines did not significantly change over time, and that the year of publication was not associated with change in adherence. From the CONSORT-related studies, the following are the factors that were reported to be significantly associated with an increase in adherence to the CONSORT Statement or to the quality of reporting of RCTs, as well as the number of studies reporting these factors: publication in CONSORT-endorsing journals (3); declared funding source (1); high impact factor (3); industrial funding (1); multicenter studies (1); non-Chinese reports (compared to those published in mainland China) (1); number of authors (1); reporting of allocation concealment (1); reporting in a medical journal (1); reporting method of sequence generation (1); sample size (3); trial quality (1); type of intervention (pharmacologic intervention versus nonpharmacologic intervention); and year of publication (before and after CONSORT) (9) . These factors are summarized in Table 4 . Having a positive outcome in RCTs (compared to a neutral or negative outcome) was the only factor reported to be significantly associated with a decrease in adherence to the CONSORT Statement (Spearman correlation = −0.192; 95% CI, −0.351 to −0.011). 55 Other factors that reported but did not reach statistical significance for an association with adherence to the CONSORT Statement are also summarized in Table 4 .
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The mean global score of the 50 included studies was 16.6 ± 2.4. Twenty-one (42%) out of the 50 studies had a global score of 17 or more. The items with the lowest scores were question 5, "Was information on included and excluded studies provided?" and question 6, "Were the characteristics of included studies provided?" with only 16% and 32% of the studies reporting each of these items correctly, respectively.
Discussion
We undertook a systematic scoping review of systematic reviews to investigate the adherence to reporting guidelines submit your manuscript | www.dovepress.com that included the CONSORT, PRISMA, QUOROM, TREND, MOOSE, and STROBE statements. Our systematic review included 50 studies that fulfilled our inclusion criteria, most of which originated from North American and European countries (43/50 studies). Despite the widespread acceptance of the CONSORT Statement and its subsequent extensions, the standards of reporting of clinical studies remained suboptimal. Our study showed that 86.0% of the systematic reviews included in this study concluded that there was a suboptimal quality of reporting across multidisciplinary clinical research topics using different study designs including RCTs and observational studies. The adherence of the assessed studies to reporting standards were not specific to any field of clinical research, but rather spanned across various disciplines including diagnostic procedures, interventions, cancer trials, and alternative medicine, implying the widespread lack of adherence to reporting guidelines in the medical literature. Despite the availability of guidelines and operational definitions of how to use these guidelines to improve reporting and transparency of clinical literature (including providing checklists, flow diagrams, and explicit methods of recruitment and allocation 12 ), the uptake of these guidelines remained low. Several shortcomings of the reporting standards of clinical literature include inadequate reporting of the methods, selective reporting of the results, or misinterpretation of the results. 91 Studies have shown that the use of these guidelines was associated with better reporting of studies of acupuncture trials, 92 and only minimal improvement in the adherence to reporting guidelines of studies that investigated diagnostic accuracy. 93 It is possible that the lack of adherence may relate to the narrow focus of these guidelines on specific clinical areas or study designs, and therefore further guidelines need to be developed. Such new guidelines can be developed based on sets of tools and criteria, as proposed previously. 94 The poor adherence to reporting guidelines seen in the clinical literature is also seen in other settings including the failure to follow the National Institute of Health guidelines for reporting sex and ethnicity in clinical trials. 95 Efforts to address the gap between the standards set by the guidelines and the actual standards of the published literature are therefore needed.
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The most striking observation from our study was the lack of consistency in methods of recording the adherence to the reporting guidelines, and therefore it was not possible to combine the results to provide a summary statistic. This highlights the need for a consensus statement on the reporting of methodological quality of studies addressing the adherence to CONSORT and other statements.
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Despite the suboptimal adherence to reporting guidelines in most of the studies reviewed, we observed that RCTs have a better adherence to reporting standards than nonRCTs. In addition, studies published in journals endorsing the CONSORT Statement have higher adherence to reporting standards. Not surprisingly, studies published after the introduction of CONSORT showed a better reporting quality and adherence to reporting guidelines. These findings are encouraging and provide a platform to disseminate knowledge generated by this study to multiple disciplines in health research to stress the need for improvement in adherence to reporting guidelines.
The strengths of our study are that we conducted a rigorous systematic review and included studies investigating the quality of reporting across various clinical areas of research, thus adding a scoping review methodology to a systematic review. We have also extracted relevant data and attempted to provide a summary statistic; however, the diversity of the findings did not allow for the computation of results.
Our study results are limited by the lack of reviews addressing adherence standards to other guidelines (MOOSE, TREND, QUOROM), the inability to combine the overall study findings, and the unavailability of tools designed to assess the quality of systematic reviews investigating methodological quality. Furthermore, the design, conduct, analysis, and reporting of the results of the reviews including definitions of outcomes (and predictor variables) varied substantially within and between the guidelines. This is mainly due to the lack of an established framework or standard for the conduct and reporting of reviews assessing the adherence to guidelines.
The study findings are nonetheless important for educators, authors, editors, sponsors, health consumers, and research ethics boards.
Summary and recommendations
Factors that are associated with reporting standards can be grouped into four categories:
• Study design: Better reporting standards were seen in studies with large sample sizes; RCT design; transparency in reporting randomization, adverse events, and secondary outcomes; and studies of drug interventions.
• Timing of publication: Studies that were published more recently were associated with better quality of reporting.
• Study sponsor: Studies with an industrial sponsor were also associated with a better quality of reporting.
• Journal: Journals with a high impact factor and those endorsing the CONSORT Statement and its extensions tended to publish studies with better adherence to reporting standards.
Recommendations for educators
Educators are at the forefront of teaching research methodology and applications in clinical settings, and therefore they play an important role in improving the reporting standards of clinical literature. Educators need to emphasize the importance of reporting standards and incorporate the guidelines in research training. They also need to provide ongoing training through workshops at professional meetings, and highlight the factors shown to improve the quality of reporting to foster improved reporting standards of the clinical literature.
Recommendations for authors
Authors should use the reporting standards appropriate to the study design as a guide to planning and reporting studies, and provide a flow diagram and checklist that will not only improve the reporting standard and adherence to guidelines, but will also help with transparency and reproducibility of the study. The use of the guidelines will also help to minimize reporting bias. For resources on using reporting standards, see the EQUATOR Network website.
12
Recommendations for editors
Studies published in journals endorsing the CONSORT and its extensions were described as having better reporting quality and increased adherence to guidelines. Therefore, editors must endorse the reporting standards as part of their journal editorial policy. Furthermore, inclusion of the respective guideline checklist must also be part of the editorial policy. Editors need to consider assessing the adherence to reporting guidelines as a requirement for peer review, and they should revise the peer review process to incorporate these assessments.
Recommendations for sponsors
Sponsors can ensure that the quality of the study methodology and transparency are meeting these standards by requesting adherence to the respective reporting guidelines appropriate for the study design.
Recommendations for research ethics boards
Institutional Review Boards or Research Ethics Boards have a substantial responsibility to ensure ethical and sound submit your manuscript | www.dovepress.com Dovepress Dovepress methodological quality of clinical studies. Therefore, we recommend that Institutional Review Boards/Research Ethics Boards require that protocols be submitted for ethical approval to clearly state what reporting standards the study will be using based on the study design, and that reporting guidelines checklist are part of the application for ethics approval.
Recommendation for health consumers
In accordance with the general principles of evidence-based health care practice, 96 we encourage consumers or health care users to be actively involved in their health care by discussing their care options with their providers. Understanding information presented in published studies can be an important ingredient in these discussions. We suggest that health care users consider the evaluation of the quality of the information presented in the literature by looking for a guideline statement and a checklist to ensure the study reporting followed a certain standard that is appropriate for the particular study design.
Lastly, one element that all parties need to take into consideration is the importance of conducting large studies. Large studies have been shown to have a better quality of reporting. 81, 84, 97 Large studies are also less prone to problems of bias and have better precision.
Conclusion
Reporting guidelines help to improve the quality and transparency of clinical studies and allow for systematic reviews and meta-analyses to provide evidence worthy of changing practice, improving knowledge, and better management of health and disease. The current reporting standards and adherence to guidelines are poor and are in need of major improvement. Steps need to be taken by all involved in the conducting and reporting of clinical research in order to achieve better standards of reporting, thus minimizing bias and providing reproducible studies that can be combined to reach conclusive evidence.
